Vertex to Present at the RBC Global Healthcare Conference on February 25
2014 RBC Capital Markets' Global Healthcare Conference
BOSTON -- February 20, 2014
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it
will be presenting at the 2014 RBC Capital Markets Global Healthcare
Conference on Tuesday, February 25 at 1:35 p.m. ET.
The audio portion of the remarks will be accessible live through Vertex’s
website at www.vrtx.com in the “Investors” section under the “Events and
Presentations” link. To ensure a timely connection, it is recommended that
users register at least 15 minutes prior to the scheduled webcast. A replay of
the webcast will also be archived on the company’s website for a period of two
weeks following the presentation.
Vertex is a global biotechnology company that aims to discover, develop and
commercialize innovative medicines so people with serious diseases can lead
better lives. Vertex scientists and our collaborators are working on new
medicines to cure or significantly advance the treatment of cystic fibrosis,
hepatitis C, rheumatoid arthritis and other life-threatening diseases. In
addition to our clinical development programs, Vertex has more than a dozen
ongoing preclinical programs aimed at other serious and life-threatening
Founded in 1989 in Cambridge, Mass., Vertex today has research and development
sites and commercial offices in the United States, Europe, Canada and
Australia. For four years in a row, Science magazine has named Vertex one of
its Top Employers in the life sciences. For additional information and the
latest updates from the company, please visit www.vrtx.com.
Vertex Pharmaceuticals Incorporated
Michael Partridge, 617-341-6108
Kelly Lewis, 617-961-7530
Press spacebar to pause and continue. Press esc to stop.